This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Braunwald, E. Articles by Sigwart, U. Search for Related Content PubMed PubMed Citation Articles by Braunwald, E. Articles by Sigwart, U. Pubmed/NCBI databases Medline Plus Health Information Cardiomyopathy Related Collections Pacemaker Hypertrophy CV surgery: transplantation, ventricular assistance, cardiomyopathy Genetics of cardiovascular disease

(Circulation. 2002;106:1312.)
© 2002 American Heart Association, Inc.

Clinician Update

Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy

Eugene Braunwald, MD; Christine E. Seidman, MD; Ulrich Sigwart, MD

From Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital (E.B., C.E.S.), and Howard Hughes Medical Institute and Department of Genetics (C.E.S.), Harvard Medical School, Boston, Mass; and the Cardiology Division, University of Geneva, Geneva, Switzerland (U.S.).

Correspondence to Eugene Braunwald, MD, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail ebraunwald@partners.org

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
This discussion of the evaluation and management of hypertrophic cardiomyopathy revolves around two illustrative cases.

	Patient A: Hypertrophic Cardiomyopathy With Obstruction

 
A 42-year-old woman was referred for evaluation of progressive exertional dyspnea and fatigue over the past 2 years. Both symptoms were greatly intensified during paroxysms of atrial fibrillation, which occur every 3 or 4 months. The patient was asymptomatic until 5 years ago, when she suffered a single syncopal episode precipitated by a bout of coughing in the erect position. She subsequently experienced episodes of presyncope under similar circumstances and at increasing frequency, but she learned to abort frank syncope by immediately lying or sitting down. Examination revealed a grade 3/6 systolic murmur along the left sternal border and at the apex. The diagnosis of obstructive hypertrophic cardiomyopathy (HCM) was established by 2-dimensional and Doppler echocardiography, which showed asymmetric septal hypertrophy, a subaortic systolic pressure gradient at rest estimated at 80 mm Hg, and mild mitral regurgitation. Her symptoms did not respond to the sequential administration of atenolol, verapamil, disopyramide, or the combination of atenolol and disopyramide. Although amiodarone reduced the frequency of the paroxysms of atrial fibrillation, she has required cardioversion for individual episodes and receives warfarin.

HCM has been diagnosed by echocardiography in her 20-year-old daughter; her 11- and 9-year-old sons have shown no abnormalities on clinical examination. There is no history suggestive of HCM in her deceased grandparents, her living parents, or her 5 siblings.

Explanation of the Clinical Presentation
Obstruction to left ventricular outflow occurs in approximately 25% of patients with HCM. Indeed, many of the . . . [Full Text of this Article]

This article has been cited by other articles:

				A. W. ElBardissi, J. A. Dearani, R. A. Nishimura, S. R. Ommen, J. M. Stulak, and H. V. Schaff Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy Mayo Clin. Proc., December 1, 2007; 82(12): 1516 - 1522. [Abstract] [Full Text] [PDF]

				E. E. Jweied, R. D. McKinney, L. A. Walker, I. Brodsky, A. S. Geha, M. G. Massad, P. M. Buttrick, and P. P. de Tombe Depressed cardiac myofilament function in human diabetes mellitus Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2478 - H2483. [Abstract] [Full Text] [PDF]

				M. J Wood and M. H Picard Utility of echocardiography in the evaluation of individuals with cardiomyopathy Heart, June 1, 2004; 90(6): 707 - 712. [Full Text] [PDF]

				C. J. McMahon, S. F. Nagueh, R. H. Pignatelli, S. W. Denfield, W. J. Dreyer, J. F. Price, S. Clunie, L. I. Bezold, A. L. Hays, J. A. Towbin, et al. Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy Circulation, April 13, 2004; 109(14): 1756 - 1762. [Abstract] [Full Text] [PDF]

				R. A. Nishimura and D. R. Holmes Jr. Hypertrophic Obstructive Cardiomyopathy N. Engl. J. Med., March 25, 2004; 350(13): 1320 - 1327. [Full Text] [PDF]

				B. J. Maron, N. A. M. Estes III, M. S. Maron, A. K. Almquist, M. S. Link, and J. E. Udelson Primary Prevention of Sudden Death as a Novel Treatment Strategy in Hypertrophic Cardiomyopathy Circulation, June 17, 2003; 107(23): 2872 - 2875. [Full Text] [PDF]

				S. Steinbis Hypertrophic Obstructive Cardiomyopathy and Septal Ablation Crit. Care Nurse, June 1, 2003; 23(3): 47 - 50. [Full Text] [PDF]

				M. Penas-Lado, R. Barriales-Villa, L. Monserrat, E. Braunwald, C. Seidman, and U. Sigwart Treatment of Hypertrophic Cardiomyopathy * Response Circulation, April 29, 2003; 107 (16): e110 - e110. [Full Text] [PDF]